±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 10:00~10:15 AJCC cancer staging 8th ed. for Colon and Rectal Cancer ¾Èżº(¼øõÇâÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 10:15~10:30 Clinical significance of lymph node micrometastasis in colorectal cancer È«±¤´ë (°í·ÁÀÇ´ë ) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 10:30~10:45 Do we need chemotherapy in low risk patients of stage II colon cancer? ¹è¼º¿í(°è¸íÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 10:45~11:00 Management for geriatric patients with colorectal cancer ÀÌÀαÔ(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 11:00~11:15 Oxaliplatin-based adjuvant chemotherapy : Choice and duration Áö¿õ¹è (°í·ÁÀÇ´ë ) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 11:15~11:30 Neoadjuvant chemotherapy for locally advanced colon cancer ¹Ú¼ö¿¬(°æºÏÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 11:30~11:45 Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy ¹é½ÂÇõ(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 11:45~12:00 Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) ÀÌÀ±ÅÃ(°í·ÁÀÇ´ë) ½Ä»ç 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 12:00~13:00 Friends I met in Camino ÀÌ ¼® ȯ(°æÈñÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 13:00~13:15 Optimal interval to surgery after preoperative CCRT in rectal cancer ¹é¼º±Ô(°è¸íÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 13:15~13:30 Treatment Strategies for cT1/ or pT1 in very low-lying rectal cancer °¼º¹ü(¼¿ïÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 13:30~13:45 Do we still need TME after preop CCRT? ±èÈñö(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 13:45~14:00 Total neoadjuvant therapy for locally advanced rectal cancer À̼®È¯(°æÈñÀÇ´ë) ÈÞ½Ä 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 14:00~14:20 Break () ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 14:20~14:35 Chemotherapy for resectable colorectal liver metastasis/ Best time for liver resection? ¹Ú¼±Áø(°æÈñÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 14:35~14:50 Choice for 1st line Chemotherapy with Targeted Agent for potentially resectable CRLM ¼Õ°æ¸ð(ºÎ»êÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 14:50~15:05 Choice for 2nd line Chemotherapy with Targeted Agent for metastatic colorectal cancer ±èÁöÈÆ(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 15:05~15:20 Choice for 3rd line Chemotherapy with Targeted Agent for metastatic colorectal cancer ¹è±â¹ü(ÀÎÁ¦ÀÇ´ë) ÈÞ½Ä 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 15:20~15:40 Break () ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 15:40~15:55 Surgery CASE I .(.) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 15:55~16:05 Surgery CASE II .(.) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 16:05~16:20 Surgery CASE III .(.) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 16:20~16:35 Surgery CASE IV .(.) ±³À°½Ã°£ 11-09 °í·Á´ëÇб³ ¾È»êº´¿ø 2Ãþ ´ë°´ç 16:35~16:50 Surgery CASE V .(.)